Recursion Pharmaceuticals Inc is trading 5.6% down today at $3.04 as investors rotate out of higher-risk growth and AI-related names following recent macro and rate jitters.
- The decline extends weakness observed after last week’s post-earnings rebound.
- With no new company-specific headlines, the stock appears to be tracking broader risk-off sentiment across the technology and biotech sectors.